iRhythm Technologies, Inc. (I25.F)

Compare

88.00

-2.50

(-2.76%)

At close: April 4 at 4:18:18 PM GMT+2

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

With the business potentially at an important milestone, we thought we'd take a closer look at iRhythm Technologies...

Simply Wall St. yesterday

IRTC
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

StockStory 2 days ago

IRTC

DXCM

MASI
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported symptoms are an unreliable predictor of arrhythmic eventsSAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago, IL. Drawing on data from

GlobeNewswire 5 days ago

IRTC
3 Healthcare Stocks in the Doghouse

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 5.9%. This performance was discouraging since the S&P 500 held steady.

StockStory 11 days ago

ABBV

IRTC
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

StockStory 15 days ago

PODD

DXCM

IRTC
iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know

iRhythm Technologies (IRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks 19 days ago

IRTC
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest of the patient monitoring stocks fared in Q4.

StockStory 25 days ago

RMD

DXCM

IRTC
1 Growth Stock to Target This Week and 2 to Ignore

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

StockStory last month

COIN

IRTC

RELY
iRhythm Technologies Full Year 2024 Earnings: Beats Expectations

iRhythm Technologies ( NASDAQ:IRTC ) Full Year 2024 Results Key Financial Results Revenue: US$591.8m (up 20% from FY...

Simply Wall St. last month

IRTC
iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

iRhythm Technologies Inc (IRTC) reports a 24% revenue increase and its first positive adjusted net income, while navigating potential tariffs and regulatory challenges.

GuruFocus.com last month

IRTC
VitalConnect raises $100M for heart monitor patch

VitalConnect will use the money to commercialize the monitor, which detects arrhythmias and competes with patches from companies including iRhythm.

MedTech Dive last month

IRTC
iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24% year on year to $164.3 million. The company expects the full year’s revenue to be around $680 million, close to analysts’ estimates. Its non-GAAP profit of $0.01 per share was significantly above analysts’ consensus estimates.

StockStory last month

IRTC
IRhythm Technologies (IRTC) Beats Q4 Earnings and Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 103.33% and 4.19%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

IRTC
iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Revenue of $164.3 million, a 24.0% increase compared to fourth quarter 2023Gross margin of 70.0%, a 410-basis point increase compared to fourth quarter 202

GlobeNewswire last month

IRTC
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

StockStory last month

IRTC

RMD
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know

IRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks last month

IRTC

OM
A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Key Insights The projected fair value for iRhythm Technologies is US$121 based on 2 Stage Free Cash Flow to Equity...

Simply Wall St. last month

IRTC
iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2024 after the close of trading on Thursday, February 20, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties m

GlobeNewswire last month

IRTC
Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?

iRhythm Technologies, Inc. ( NASDAQ:IRTC ), might not be a large cap stock, but it saw a significant share price rise...

Simply Wall St. 2 months ago

IRTC
iRhythm price target raised to $125 from $112 at Needham

Needham analyst David Saxon raised the firm’s price target on iRhythm (IRTC) to $125 from $112 and keeps a Buy rating on the shares as part of a broader research note on MedTech/Diagnostics sector. Following the recent pre-announcements and management commentary, the firm is updating its forecasts on select names while also rolling forward its valuation framework to 2026 estimates, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-time, mark

TipRanks 2 months ago

IRTC

Performance Overview

Return	I25.F	S&P 500 (^GSPC)
YTD	+4.76%	-13.73%
1-Year	-12.87%	-1.42%
3-Year	-40.54%	+10.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

iRhythm Technologies, Inc. (I25.F)

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

3 Healthcare Stocks in the Doghouse

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

1 Growth Stock to Target This Week and 2 to Ignore

iRhythm Technologies Full Year 2024 Earnings: Beats Expectations

iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

VitalConnect raises $100M for heart monitor patch

iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars

IRhythm Technologies (IRTC) Beats Q4 Earnings and Revenue Estimates

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know

A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?

iRhythm price target raised to $125 from $112 at Needham

Performance Overview